📋 Tender Overview
Contract awarded for Next generation sequencing device (ngs) lot-0000, title: next generation sequencing device (ngs), description: the procurement item is a next generation sequencing device (ngs) supporting multi-omics, aviti24, device-specific consumables, and a maintenance contract. the device is intended for targeted sequencing, exome sequencing, whole genome sequencing, transcriptome sequencing, and multi-omics requiring cell profiling from human-derived sample materials. the device specifically produces information that supports cancer diagnostics and guides cancer treatment. aviti24 is currently the only device available on the market that can meet the technical and cost requirements set for the device to be procured. the specific requirements for the device are as follows: the device can sequence a wide range of gene libraries prepared with reagents from different manufacturers from fresh and ffpe samples. sequencing capacity of at least 1 b sequences/40gb-480gb in one run, sequencing length of at least 2*150bp, sample multiplexing capability from dozens to several hundred samples in one run, various sizes of sequencing cassettes must be available (75bp, 150bp, 300bp), the device must be easy to use and highly automated (pre-packaged reagent kits), the device must have two separate sequencing units where one run can be started while the other is ongoing, the device produces at least > 90% q30 quality sequencing data in a 2x150bp run, data quality can achieve 70% q50 and 90% q40 quality criteria with special reagents, the device can prepare a hybridization-based sequencing library inside the device, and the device can perform multi-omics directly from cells and tissues (rna, proteins, and cell morphology). the device produces sequencing data at the most cost-effective prices on the market. estimated value excluding vat: 570400.00 eur.Next generation sequencing device (ngs)
